Compare BSTZ & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSTZ | INVA |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 2000 |
| Metric | BSTZ | INVA |
|---|---|---|
| Price | $22.37 | $22.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | 178.6K | ★ 776.5K |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | ★ 8.31% | N/A |
| EPS Growth | N/A | ★ 816.67 |
| EPS | 0.71 | ★ 3.30 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | N/A | $11.99 |
| P/E Ratio | $31.33 | ★ $6.78 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $15.22 | $16.52 |
| 52 Week High | $23.47 | $25.15 |
| Indicator | BSTZ | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 43.56 | 55.92 |
| Support Level | $22.17 | $18.91 |
| Resistance Level | $23.13 | N/A |
| Average True Range (ATR) | 0.44 | 0.84 |
| MACD | -0.07 | -0.16 |
| Stochastic Oscillator | 21.35 | 22.99 |
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.